Medicofarma Biotech Spolka Akcyjna Logo

Medicofarma Biotech Spolka Akcyjna

A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.

MDB | WAR

Overview

Corporate Details

ISIN(s):
PLINBOK00010
LEI:
259400W39H7UHW9EJP66
Country:
Poland
Address:
Warszawa Sokołowska 9/U19, 01-142 Warszawa
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Medicofarma Biotech is a research and development company operating in the biotechnology sector. The company's core mission is to design, refine, and introduce innovative drugs, medical devices, and biotechnological products. It focuses on developing breakthrough solutions for the prevention and treatment of modern-age diseases, with a particular emphasis on innovative oncology therapies. The company's R&D center collaborates with pharmaceutical producers and scientific institutions, providing specialized personnel and equipment for the initial pre-formulation stages of generic medicinal and cosmetic products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-04-18 18:43
Share Issue/Capital Change
Wprowadzenie do ASO na rynku NewConnect akcji serii G i H oraz złożenie wniosku…
Polish 1.3 KB
2024-03-06 19:35
Capital/Financing Update
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
Polish 3.3 KB
2024-01-03 22:51
Share Issue/Capital Change
Złożenie wniosku o wprowadzenie akcji serii G i H do obrotu w ASO na rynku NewC…
Polish 1.7 KB
2024-01-02 17:16
Share Issue/Capital Change
Korekta raportu bieżącego ESPI nr 11/2023 - Content (PL)
Polish 4.5 KB
2023-12-31 19:41
Capital/Financing Update
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
Polish 2.1 KB
2023-12-31 19:33
Legal Proceedings Report
Zawarcie umów ograniczających rozporządzanie akcjami Spółki - Content (PL)
Polish 2.9 KB
2023-12-31 19:24
Investor Presentation
Strategia na lata 2024-2026
Polish 2.6 MB
2023-12-31 19:24
Business and Financial Review
Przyjęcie strategii Spółki na lata 2024 - 2026 - Content (PL)
Polish 1.8 KB
2023-10-26 22:42
Capital/Financing Update
Zawarcie aneksu do umowy pożyczki z podmiotami powiązanymi - Content (PL)
Polish 2.5 KB
2023-10-23 20:42
Regulatory News Service
Zawarcie umowy o dofinansowanie projektu wybranego w ramach konkursu NUTRITECH …
Polish 6.3 KB
2023-10-11 21:07
Legal Proceedings Report
Otrzymanie wyników wstępnego międzynarodowego poszukiwania dot. stanu techniki …
Polish 1.9 KB
2023-07-20 19:38
Report Publication Announcement
Najwyższa ocena merytoryczna wniosku dotacyjnego NUTRITECH - Content (PL)
Polish 1.2 KB
2023-07-19 18:01
Regulatory News Service
Informacja o uzyskaniu certyfikatu GMP - Content (PL)
Polish 716 bytes
2023-06-30 22:59
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Walnym Zgroma…
Polish 766 bytes
2023-06-02 15:22
Management Discussion and Analysis
Medicofarma_Biotech_SA_Sprawozdanie_Rady_Nadzorczej_2022_20230602_sent.pdf
Polish 345.3 KB

Automate Your Workflow. Get a real-time feed of all Medicofarma Biotech Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medicofarma Biotech Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medicofarma Biotech Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Isofol Medical Logo
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden ISOFOL
B2B platform for Ukraine-Korea trade, investment, and post-war reconstruction.
South Korea 052770
IVISIONWORKS CO.,LTD. Logo
Accelerates social impact startups & develops digital therapeutics for cognitive rehabilitation.
South Korea 469750
A diversified, Asia-focused conglomerate with businesses in property, retail, auto, and more.
Bermuda N/A
The world's largest uranium producer, managing the front-end of the global nuclear fuel cycle.
Kazakhstan N/A
KAINOS MEDICINE, INC. Logo
Develops small molecule drugs for neurodegenerative diseases, cancers, and infectious diseases.
South Korea 284620
Kanamoto Co., Ltd. Logo
Global provider of rental construction equipment, also selling used machinery and steel products.
Japan 9678
Keihan Holdings Co.,Ltd. Logo
A conglomerate integrating transport, real estate, and retail for regional development.
Japan 9045
KNT-CT Holdings Co.,Ltd. Logo
A travel holding company offering themed tours and corporate travel solutions to boost Japan tourism.
Japan 9726
KoBioLabs, Inc. Logo
Develops AI-driven microbiome therapeutics for immune, metabolic, and brain disorders.
South Korea 348150

Talk to a Data Expert

Have a question? We'll get back to you promptly.